Thrombophilia-associated pregnancy wastage

被引:98
作者
Blumenfeld, Z [1 ]
Brenner, B
机构
[1] Technion Israel Inst Technol, Rambam Med Ctr, Dept Obstet & Gynecol, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Thrombosis & Hemostasis Unit, Inst Hematol, IL-31096 Haifa, Israel
关键词
thrombophilia; pregnancy wastage; factor V Leiden; hyperhomocysteinemia; anticardiolipin; protein S; protein C; antithrombin III; MTHFR; factor II;
D O I
10.1016/S0015-0282(99)00360-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To critically review the literature regarding inherited thrombophilia and recurrent fetal loss. Design: English-language literature review. Patient(s): Women who experienced repeated pregnancy wastage. Intervention(s): Aspirin, glucocorticoids, heparin, and IV immunoglobulin for the prevention of miscarriage. Main Outcome Measure(s): Live birth, miscarriage, preeclampsia, and pregnancy loss. Result(s): Recurrent fetal loss and other placental vascular pathologies of pregnancy have long been associated with antiphospholipid syndrome, an acquired autoimmune thrombophilic state. The number of known heritable thrombophilic disorders has grown rapidly in recent years with the identification of activated protein C resistance, factor V Leiden mutation, and hyperhomocysteinemia as major causes of thrombosis. Data accumulated over the past 2 years suggest that heritable thrombophilia is associated with an increased risk of fetal loss and preeclampsia. The present review discusses potential pathogenetic mechanisms for this association and evaluates reported therapeutic regimens for the prevention of fetal loss in women with thrombophilia. Conclusion(s): placental thrombosis may be the final common pathophysiologic pathway in most women with habitual abortions and repeated pregnancy wastage. Prophylactic antithrombotic therapy is indicated in women with heritable thrombophilia and antiphospholipid syndrome and probably is more effective than the previously used modalities of prednisone, aspirin, and IV immunoglobulin. (Fertil Steril(R) 1999,72:765-74. (C) 1999 by American Society for Reproductive Medicine.).
引用
收藏
页码:765 / 774
页数:10
相关论文
共 99 条
[81]  
SALAFIA CM, 1996, ANTIPHOSPHOLIPID SYN, P117
[82]   PREECLAMPSIA, DELIVERY, AND THE HEMOSTATIC SYSTEM [J].
SALEH, AA ;
BOTTOMS, SF ;
WELCH, RA ;
ALI, AM ;
MARIONA, FG ;
MAMMEN, EF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (02) :331-336
[83]  
Sanson BJ, 1996, THROMB HAEMOSTASIS, V75, P387
[84]  
SCOTT JR, 1987, OBSTET GYNECOL, V70, P645
[85]   VITAMIN STATUS AND INTAKE AS PRIMARY DETERMINANTS OF HOMOCYSTEINEMIA IN AN ELDERLY POPULATION [J].
SELHUB, J ;
JACQUES, PF ;
WILSON, PWF ;
RUSH, D ;
ROSENBERG, IH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (22) :2693-2698
[86]   COMPARATIVE TRIAL OF PREDNISONE PLUS ASPIRIN VERSUS ASPIRIN ALONE IN THE TREATMENT OF ANTICARDIOLIPIN ANTIBODY-POSITIVE OBSTETRIC PATIENTS [J].
SILVER, RK ;
MACGREGOR, SN ;
SHOLL, JS ;
HOBART, JM ;
NEERHOF, MG ;
RAGIN, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (06) :1411-1417
[87]   Lack of association between antiphospholipid antibodies and first-trimester spontaneous abortion: prospective study of pregnancies detected within 21 days of conception [J].
Simpson, JL ;
Carson, SA ;
Chesney, C ;
Conley, MR ;
Metzger, B ;
Aarons, J ;
Holmes, LB ;
Jovanovic-Peterson, L ;
Knopp, R ;
Mills, JL .
FERTILITY AND STERILITY, 1998, 69 (05) :814-820
[88]   A PROSPECTIVE-STUDY OF PLASMA HOMOCYST(E)INE AND RISK OF MYOCARDIAL-INFARCTION IN UNITED-STATES PHYSICIANS [J].
STAMPFER, MJ ;
MALINOW, MR ;
WILLETT, WC ;
NEWCOMER, LM ;
UPSON, B ;
ULLMANN, D ;
TISHLER, PV ;
HENNEKENS, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (07) :877-881
[89]   MATERNAL HYPERHOMOCYSTEINEMIA - A RISK FACTOR FOR NEURAL-TUBE DEFECTS [J].
STEEGERSTHEUNISSEN, RPM ;
BOERS, GHJ ;
TRIJBELS, FJM ;
FINKELSTEIN, JD ;
BLOM, HJ ;
THOMAS, CMG ;
BORM, GF ;
WOUTERS, MGAJ ;
ESKES, TKAB .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (12) :1475-1480
[90]   RESISTANCE TO ACTIVATED PROTEIN-C AS A BASIS FOR VENOUS THROMBOSIS [J].
SVENSSON, PJ ;
DAHLBACK, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (08) :517-522